Markets | | The equity markets have seen unprecedented volatility in 2020 triggered by the COVID-19 pandemic black swan event. The S&P 500 ETF (NYSEARCA: SPY) has broken all kinds of records including the fastest drop into a bear market in history collapsing in excess of (-30 percent) from highs in just thr... Read the Full Story |
|
From Our Partners | | A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years.
While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million.
One company controls the entire supply chain behind this discovery. | | See the ticker behind this Grand Canyon energy breakthrough now |
|
Markets | | Even as the major indices have been setting records for intra-day and intra-week swings and volatility reaches never before seen heights, there are some stocks, who by their mechanics, are destined to move even faster. Welcome to the world of 2x and 3x ETFs. These guys use debt and or derivatives to... Read the Full Story |
|
Markets | | The storied history of Bitcoin (BTC) reveals how the very first block aptly referred to as the Genesis Block, was mined by its anonymous creator Satoshi Nakamoto on January 3, 2009. On that Genesis Block was the inscription, “The Times 03/Jan/2009 Chancellor on bringing of the second bailout f... Read the Full Story |
|
From Our Partners | | Matt Monaco started with a $2,000 trading account and no clear strategy. After two years of trial and error, he crossed $1 million in 2020.
Today his account sits at $3 million, generating roughly $100,000 a month using a repeatable system he calls The Income Blueprint.
He's revealing the exact five-step scan and three trading lanes behind it in a free live training. | | Reserve your seat and claim The Income Blueprint free |
|
Markets | | Sell The Rumor, Buy The News
JonesTrading Chief Market Strategies Mike O’Rourke says we are on the brink of Bear-Maggedon. Bear-Maggedon, to him, is the toxic-combination economic-rollover in the face of easy money policy. In this environment, investors will begin to fear the Fed’s abil... Read the Full Story |
|
Markets | |
Sometimes, when market volatility is on the rise, finding places that can protect your money and avoid downside risk is huge. One of the crucial things to understand about investing is that risk is always a possibility. If you look at the recent volatility in the market, you might be wondering whe... Read the Full Story |
|
From Our Partners | | Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film.
Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business. | | Watch the full investigation and decide for yourself |
|
Markets | |
Dollar General (NYSE:DG) delivered a strong fourth-quarter earnings report. The report also closed out the company’s 2019 fiscal year. By every measure that is important to investors, the company delivered good news. Quarterly earnings were better than expected. Quarterly revenue was a sligh... Read the Full Story |
|
Markets | |
Learning that the stock market is going down is never easy news for long-term investors to process. However, there’s a substantial difference between seeing the market go down for a small dip and seeing it experience a historically massive drop like on Monday. Investors just experienced one ... Read the Full Story |
|
Markets | | Looking For Growth And Yield? Here It Is
There is no question that we are witnessing one of the greatest buying opportunities of our lifetime. The S&P 500 is down about 20% from its highs offering a discount to prices we may not see again. I say may not see again because prices could bounce hig... Read the Full Story |
|
Markets | |
So the last couple weeks have been a bit of a white-knuckled panic as we seemingly race to the bottom. With the S&P 500 futures market activating limit-down circuit breaker protections after losing 7%, it's easy to start thinking disaster is on the horizon. Yet recent reports from a range of m... Read the Full Story |
|
Markets | | A bear market is defined as a stock market that has fallen (-20 percent) or more from all-time highs (ATH) and lasting 60-days or more. The image of a bear clawing down illustrates the direction of stock prices coming down during this market phase. Bear markets often precede recessions due to the la... Read the Full Story |
|
The Early Bird Stock Of The Day NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida. | | View Today's Stock Pick |
|
